Literature DB >> 23419837

Refractory heparin induced thrombocytopenia with thrombosis (HITT) treated with therapeutic plasma exchange and rituximab as adjuvant therapy.

Amy M Schell1, Melissa Petras, Zbigniew M Szczepiorkowski, Deborah L Ornstein.   

Abstract

We report a case of refractory heparin-induced thrombocytopenia with thrombosis (HITT) with prolonged thrombocytopenia and multiple thrombotic complications that failed to improve despite aggressive treatment. A 60 year old female with a prior history of venous thromboembolism was admitted with an acute pulmonary embolism, and developed HITT after several days on heparin therapy. She suffered multiple complications including bilateral venous limb gangrene, acute renal failure, and refractory thrombocytopenia, leading us to use multimodality therapy including therapeutic plasma exchange (TPE) and rituximab immunosuppression. The patient had transient improvements in her thrombocytopenia with TPE, and rituximab was added in an attempt to reduce antibody production. She eventually required bilateral limb amputation, and only after removal of the gangrenous limbs did her platelet count show sustained improvement. We discuss the possible contribution of infection to her prolonged course.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BKA; Corticosteroids; HIT; Heparin induced thrombocytopenia with thrombosis; ODU; Phlegmasia cerulea dolans; Rituximab; TPE; Therapeutic plasma exchange; below-knee amputations; heparin induced thrombocytopenia; optical density units; therapeutic plasma exchange

Mesh:

Substances:

Year:  2013        PMID: 23419837     DOI: 10.1016/j.transci.2013.01.007

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  5 in total

1.  Therapeutic plasma exchange for management of heparin-induced thrombocytopenia: Results of an international practice survey.

Authors:  Oluwatoyosi A Onwuemene; Nicole D Zantek; Marian A Rollins-Raval; Jay S Raval; Joseph E Kiss; Tina S Ipe; Maragatha Kuchibhatla; Monica B Pagano; Edward C C Wong
Journal:  J Clin Apher       Date:  2019-05-22       Impact factor: 2.821

2.  A Case of Heparin-Induced Thrombocytopenia That Developed in the Therapeutic Course of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.

Authors:  Taketoshi Nonaka; Makoto Harada; Masahiko Sumi; Wataru Ishii; Tohru Ichikawa; Mamoru Kobayashi
Journal:  Case Rep Rheumatol       Date:  2019-07-22

3.  Multiterritorial strokes in the setting of spontaneous heparin-induced thrombocytopaenia syndrome.

Authors:  Christopher Kwan; Jon Reimers; Cullen o'Gorman; Robert Bird; Helen Brown
Journal:  BMJ Case Rep       Date:  2022-02-28

Review 4.  Epidemiology and Management of Cerebral Venous Thrombosis during the COVID-19 Pandemic.

Authors:  Natalia Novaes; Raphaël Sadik; Jean-Claude Sadik; Michaël Obadia
Journal:  Life (Basel)       Date:  2022-07-22

5.  Anti-neutrophil cytoplasmic antibody-associated vasculitis accompanied by type II heparin-induced thrombocytopenia resulting in asymptomatic cerebral infarction: a case report.

Authors:  Yoshitaka Furuto; Mariko Kawamura; Jumpei Yamashita; Takahiro Yoshikawa; Akio Namikawa; Rei Isshiki; Hiroko Takahashi; Yuko Shibuya
Journal:  BMC Nephrol       Date:  2021-06-14       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.